The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.

This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.

The consequences of the anti-vaccine movement reach beyond today’s controversies. Scott Gottlieb is a former commissioner of ...

Litifilimab has the potential to be a first-in-class therapy targeting blood dendritic cell antigen 2 (BDCA2) in CLE, a chronic autoimmune skin disease that has a substantial impact on the daily life ...

The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...

Biogen’s litifilimab has received Breakthrough Therapy Designation from the US FDA to treat cutaneous lupus erythematosus ...

Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous lupus erythematosus (CLE) skin disease activityLitifil ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.

Picture living with severe pelvic pain so intense that it interferes with your work, school, time with family, daily life — ...

We’ve all been there: you’re about to enjoy a delicious meal, but one tiny, painful spot in your mouth turns every bite into ...

Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...

Assemblymember Amanda Septimo (A.D. 84) has announced that she has suspended her congressional campaign for the Democratic ...